A.P. Pharma Reviews

Recommend to a friend
Approve of CEO
(no image)
John B. Whelan
0 Ratings

A.P. Pharma Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Website www.appharma.com
Headquarters Redwood City, CA
Size 16 to 50 Employees
Founded Unknown
Type Company - Public
Industry Biotech & Pharmaceuticals
Revenue $1 to $5 million (USD) per year
Competitors Depomed, DURECT

A.P. Pharma wants to hit you where it hurts. The firm develops bioerodible polymers for injectable and implantable drug delivery. Its Biochronomer technology delivers medication directly to the site where the drug is needed. A.P. Pharma's leading drug candidate, APF530, could ease chemotherapy-induced nausea and vomiting. A second candidate in clinical trials is a post-surgical pain management product that delivers pain relief right to the surgical site. A.P. Pharma is also developing therapies for inflammation and chronic pain using its Biochronomer technology. Its ... More

Work at A.P. Pharma? Share Your Experiences

A.P. Pharma

Click to Rate